Sunderji Rubina, Fung Anthony, Gin Kenneth, Shalansky Karen, Carter Cedric
Vancouver General Hospital and University of British Columbia, Vancouver, Canada.
Can J Cardiol. 2003 Jul;19(8):931-5.
Self-management of warfarin is an evolving strategy that involves self-testing of the international normalized ratio using a point-of-care device and adjustment of warfarin dosage by the patient using a dosage-adjustment nomogram. There is mounting evidence from clinical trials that self-management of warfarin is feasible and is potentially superior to conventional management by physicians in maintaining anticoagulation control. Some advantages of this strategy are convenience, rapid availability of results with timely adjustment of warfarin dosages, increased patient responsibility for their own therapy and enhanced patient satisfaction. Access to point-of-care instruments may prove particularly valuable for patients without ready access to laboratories, frequent travellers who are often away from their home laboratory for extended periods of time and those who experience difficulties with venous blood collection. Self-management may be considered for carefully selected and properly trained individuals. Information from several ongoing clinical trials will aid in determining the value of anticoagulation self-management with respect to complication rates and economic outcomes.
华法林自我管理是一种不断发展的策略,包括使用即时检测设备进行国际标准化比值的自我检测,以及患者使用剂量调整对照表来调整华法林剂量。临床试验中有越来越多的证据表明,华法林自我管理是可行的,并且在维持抗凝控制方面可能优于医生的传统管理。该策略的一些优点包括方便、结果快速可得以便及时调整华法林剂量、患者对自身治疗的责任感增强以及患者满意度提高。对于无法方便使用实验室的患者、经常长时间离家的频繁旅行者以及静脉采血有困难的患者而言,使用即时检测仪器可能特别有价值。对于经过精心挑选和适当培训的个体,可以考虑采用自我管理。来自几项正在进行的临床试验的信息将有助于确定抗凝自我管理在并发症发生率和经济结果方面的价值。